| Name | Title | Contact Details |
|---|
Harvard Pilgrim Health Care is a full-service health benefits company serving more than one million members throughout Massachusetts, New Hampshire, Maine, Connecticut, and beyond. We`re dedicated to improving the quality and value of health care for the people and communities we serve. We recognize that health care is not one size fits all, and we`re working every day to create value for our members by respecting their unique values, languages, and cultures. For more than 40 years, we have built a reputation for exceptional clinical quality, preventive care, disease management, and member satisfaction, and have consistently been rated among the top plans in the country. In 2013 Harvard Pilgrim Health Care was ranked #1 private health plan in America for the 10th consecutive year. (#1 plan information available at http://countusin.harvardpilgrim.org/privacy) An independent, not-for-profit organization known for innovation that delivers better health and cost management, Harvard Pilgrim offers a wide variety of health insurance options for companies, families, and individuals. Our fully-insured and self-insured PPO, POS, and HMO plans are available with multiple variations tailored to the needs of our members and their employers. So, wherever, whenever you are looking for a partner in health benefits, or a great place to work, count us in. Harvard Pilgrim Health Care includes Harvard Pilgrim Health Care, Harvard Pilgrim Health Care of New England, and HPHC Insurance Company.
HealthFirst Third Party Administrators is a Tyler, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Crowne Management is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Monroeville, AL. To find more information about Crowne Management, please visit www.crownemanagement.com
Alnylam is the world`s leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market. We are developing RNAi (RNA interference) as an innovative, entirely new class of medicines to treat rare genetic, cardio metabolic, acute hepatic infectious and central nervous system (CNS) and ocular diseases. Alnylam was founded in 2002 based on a Nobel Prize-winning breakthrough in biology – the discovery of RNAi, and a bold vision that this discovery could be used to silence disease-causing genes upstream of today`s medicines. We are relentless in our pursuit of new treatments because we believe that RNAi therapeutics can be used to treat many diseases for which treatment options do not exist or are inadequate. Overall, we believe that patients shouldn`t have to wait for hope. Alnylam is turning scientific possibility into reality - in 2018, the FDA and European EMA approved of our first product, ONPATTRO (patisiran) which is also the first-ever approved RNAi therapeutic. In 2019, the FDA approved our second product, GIVLAARI (givosiran). Our robust pipeline of investigational medicines includes multiple programs in late-stage and early-stage clinical development. We are a global and diverse company of more than 1,500 people. We pride ourself on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That`s why we`ve been named a Science Magazine Top Employer for two years in a row (`19-`20), a Boston Globe Top Place to Work 5x in a row (`15-`19) and one of Fast Company`s 50 Most Innovative Companies for 2019. We are based in Cambridge, U.S., with offices throughout Europe, Asia and South America.
Encompass Health System is a West Des Moines, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.